Abiraterone and MDV3100 inhibits the proliferation and promotes the apoptosis of prostate cancer cells through mitophagy
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Cell International"
DOI: 10.1186/s12935-019-1021-9
Abstract: BackgroundAbiraterone and MDV3100 are two effective anticancer agents for prostate cancer, however, the mechanism of their downstream action remains undefined.MethodsA dual fluorescent biosensor plasmid was transfected in LNCaP cells to measure mitophagy. The DNA of… read more here.
Keywords: lncap cells; abiraterone mdv3100; cancer; proliferation ... See more keywords